Back

ResearchAndMarkets adds DLL3 therapy market report forecasting through 2036

Verifying
  • ResearchAndMarkets.com added a report covering DLL3-targeted therapies across seven major markets.
  • IMDELLTRA’s estimated seven-market value approached USD 400 million in 2025.
  • The report covers epidemiology, competition, reimbursement and forecasts from 2022 through 2036.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.